Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Improved safety of basiliximab (Simulect®) over antithymocyte globulin (Thymoglobulin®) induction therapy in heart transplantation

M MATTEI,P BOISSONNAT,M REDONNET,I GANDJBAKHCH,A MOULYBANDINI,R DORENT,C YAU,A BLANC

The Journal of Heart and Lung Transplantation（2005）

Cited 1|Views22
No score
Abstract
Antibody induction therapy is currently used in a large proportion of patients despite tolerability issues. The aim of this prospective, randomized, multicentre study was to compare basiliximab vs antithymocyte globulin (ATG) to evaluate if basiliximab could supply a benefit on tolerability with no penalty on efficacy.
More
Translated text
Key words
antithymocyte globulin,heart transplantation,basiliximab,induction therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined